MetLife Investment Management’s Octave Specialty Group OSG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $153K | Buy |
24,501
+17,082
| +230% | +$88.9K | ﹤0.01% | 2554 |
|
|
2026
Q1 | $34.5K | Sell |
7,419
-12,537
| -63% | -$71.8K | ﹤0.01% | 2709 |
|
|
2025
Q4 | $155K | Buy |
19,956
+1,603
| +9% | +$13.7K | ﹤0.01% | 2399 |
|
|
2025
Q3 | $153K | Buy |
+18,353
| New | +$155K | ﹤0.01% | 2462 |
|
|
2025
Q2 | – | Sell |
-23,542
| Closed | -$206K | – | 2771 |
|
|
2025
Q1 | $206K | Sell |
23,542
-3,296
| -12% | -$34.7K | ﹤0.01% | 2184 |
|
|
2024
Q4 | $340K | Buy |
26,838
+2,269
| +9% | +$27.4K | ﹤0.01% | 2006 |
|
|
2024
Q3 | $275K | Hold |
24,569
| – | – | ﹤0.01% | 2121 |
|
|
2024
Q2 | $315K | Buy |
24,569
+2,437
| +11% | +$37.2K | ﹤0.01% | 1978 |
|
|
2024
Q1 | $346K | Sell |
22,132
-2,434
| -10% | -$38.4K | ﹤0.01% | 1888 |
|
|
2023
Q4 | $405K | Hold |
24,566
| – | – | ﹤0.01% | 1814 |
|
|
2023
Q3 | $296K | Hold |
24,566
| – | – | ﹤0.01% | 1964 |
|
|
2023
Q2 | $350K | Hold |
24,566
| – | – | ﹤0.01% | 1926 |
|
|
2023
Q1 | $380K | Hold |
24,566
| – | – | ﹤0.01% | 1812 |
|
|
2022
Q4 | $428K | Hold |
24,566
| – | – | ﹤0.01% | 1740 |
|
|
2022
Q3 | $313K | Hold |
24,566
| – | – | ﹤0.01% | 1985 |
|
|
2022
Q2 | $279K | Hold |
24,566
| – | – | ﹤0.01% | 2065 |
|
|
2022
Q1 | $255K | Buy |
24,566
+8,759
| +55% | +$119K | ﹤0.01% | 2201 |
|
|
2021
Q4 | $254K | Buy |
15,807
+4,950
| +46% | +$77.8K | ﹤0.01% | 1915 |
|
|
2021
Q3 | $155K | Sell |
10,857
-6,078
| -36% | -$86.8K | ﹤0.01% | 2240 |
|
|
2021
Q2 | $265K | Buy |
16,935
+4,482
| +36% | +$72K | ﹤0.01% | 1974 |
|
|
2021
Q1 | $208K | Sell |
12,453
-7,248
| -37% | -$118K | ﹤0.01% | 2032 |
|
|
2020
Q4 | $303K | Sell |
19,701
-2,743
| -12% | -$40.4K | ﹤0.01% | 1766 |
|
|
2020
Q3 | $287K | Hold |
22,444
| – | – | ﹤0.01% | 1653 |
|
|
2020
Q2 | $321K | Hold |
22,444
| – | – | ﹤0.01% | 1619 |
|
|
2020
Q1 | $277K | Hold |
22,444
| – | – | ﹤0.01% | 1516 |
|
|
2019
Q4 | $484K | Hold |
22,444
| – | – | 0.01% | 1477 |
|
|
2019
Q3 | $439K | Hold |
22,444
| – | – | ﹤0.01% | 1491 |
|
|
2019
Q2 | $378K | Sell |
22,444
-44,888
| -67% | -$766K | ﹤0.01% | 1649 |
|
|
2019
Q1 | $1.22M | Buy |
67,332
+44,888
| +200% | +$857K | ﹤0.01% | 1549 |
|
|
2018
Q4 | $387K | Hold |
22,444
| – | – | ﹤0.01% | 1526 |
|
|
2018
Q3 | $458K | Hold |
22,444
| – | – | ﹤0.01% | 1591 |
|
|
2018
Q2 | $446K | Hold |
22,444
| – | – | 0.01% | 1470 |
|
|
2018
Q1 | $352K | Hold |
22,444
| – | – | ﹤0.01% | 1590 |
|
|
2017
Q4 | $359K | Buy |
+22,444
| New | +$345K | ﹤0.01% | 1597 |
|
Other funds holding OSG
WSL
PGCM
TAM
BCC
MetLife Investment Management's OSG Position: Q2 2026 in Review
MetLife Investment Management increased its Octave Specialty Group (OSG) stake by 230% in Q2 2026, buying an estimated $88.9K and bringing the position to 24,501 shares worth $153K. The position accounts for ﹤0.01% of the portfolio, ranked #2554.
MetLife Investment Management first reported a position in OSG in Q4 2017 and has held it in 34 quarters since. The position peaked at $1.22M in Q1 2019. 148 funds tracked by Wall St. Rank hold OSG as of Q2 2026.
- MetLife Investment Management held 24,501 shares of Octave Specialty Group worth $153K as of Q2 2026.
- MetLife Investment Management bought 17,082 Octave Specialty Group shares in Q2 2026, an estimated $88.9K.
- Octave Specialty Group made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2554 holding.
- MetLife Investment Management first reported a position in Octave Specialty Group in Q4 2017 and has held it in 34 quarters since.
- MetLife Investment Management's Octave Specialty Group position peaked at $1.22M in Q1 2019.
- 148 funds tracked by Wall St. Rank held Octave Specialty Group as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.